VR Logo

Gufic Biosciences Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

40 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Incorporated: 1984

Chairman: Jayesh P Choksi

Managing Director: Jayesh P Choksi

Group: --

Listing: NSE: GUFICBIO, BSE: 509079

Headquarters: Mumbai, Maharashtra

Website: www.gufic.com

Key Facts

Market cap: R 930.07 Cr

Revenue (TTM): R 400.49 Cr

Earnings (TTM): R 30.48 Cr

Cash: R 10.82 Cr

Total Debt: R 110.73 Cr

Promoters' ownership: 65.75%

Liquidity: High

52 Week range: R 37.00 - 137.45

Face value: R1.00

Shares outstanding: 7,78,30,000

10 Years Aggregate:

  • CFO: 71.12 Cr
  • EBITDA: 222.50 Cr
  • Net Profit: 92.36 Cr

Stock Performance

Time Period Gufic Biosciences S&P BSE Healthcare S&P BSE Small Cap
YTD2.18-3.8111.37
1 month2.931.1012.05
3 months7.082.6419.44
1 Year75.3454.7147.02
3 Years-0.2113.923.60
5 Years26.396.5216.13
10 Years35.6213.819.93
As on 26-Feb-2021
Year Gufic Biosciences S&P BSE Small Cap S&P BSE Healthcare
202093.4732.1161.45
2019-35.40-6.85-3.55
2018-26.15-23.41-5.89
2017138.2559.640.49
2016-4.491.77-12.88
2015225.156.7615.06